Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease-Reference-Cited by-同舟云学术

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

Published:2009-03-13 Issue:7 Volume:132 Page:1783-1794
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Neumann Juliane,Bras Jose,Deas Emma,O'Sullivan Sean S.,Parkkinen Laura,Lachmann Robin H.,Li Abi,Holton Janice,Guerreiro Rita,Paudel Reema,Segarane Badmavady,Singleton Andrew,Lees Andrew,Hardy John,Houlden Henry,Revesz Tamas,Wood Nicholas W.

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/132/7/1783/13734818/awp044.pdf

Reference48 articles.

1. A systematic review of prevalence studies of dementia in Parkinson's disease;Aarsland;Mov Disord,2005

2. The role of pathogenic DJ-1 mutations in Parkinson's disease;Abou-Sleiman;Ann Neurol,2003

3. A heterozygous effect for PINK1 mutations in Parkinson's disease?;Abou-Sleiman;Ann Neurol,2006

4. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews;Aharon-Peretz;N Engl J Med,2004

5. Gaucher's disease with Parkinson's disease: clinical and pathological aspects;Bembi;Neurology,2003

Cited by 579 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental models of Parkinson's disease: Challenges and Opportunities;European Journal of Pharmacology;2024-10

2. Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease;Translational Neurodegeneration;2024-09-12

3. Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson's Disease;Movement Disorders;2024-09-11

4. Comparing GBA1‐Parkinson's disease and idiopathic Parkinson's disease: α‐Synuclein oligomers and synaptic density as biomarkers in the skin biopsy;Brain Pathology;2024-09

5. Molecular mechanisms of the ambroxol action in Gaucher disease and GBA1 mutation-associated Parkinson disease;Neurochemistry International;2024-09